Join
Live feed
·
INSIDERFilingvia Quantisnow
Ventyx Biosciences Inc. logo

CHIEF SCIENTIFIC OFFICER Nuss John sold $29,682 worth of shares (13,161 units at $2.26) and converted options into 34,930 shares, increasing direct ownership by 5% to 485,701 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTYX· Ventyx Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTYX (Ventyx Biosciences Inc.) and more on Quantisnow.

CHIEF SCIENTIFIC OFFICER Nuss John sold $29,682 worth of shares (13,161 units at $2.26) and converted options into 34,930 shares, increasing direct ownership by 5% to 485,701 units (SEC Form 4) | Quantisnow